Jimmy Carter, who chose to forgo aggressive medical care for complications of cancer and frailty in February 2023, recently reached his one-year anniversary since…
In the past two years, the FDA has fully approved two new disease-modifying treatments for Alzheimer’s — and more of these treatments are in the…
Most older adults would prefer to age in place, but many rely on paid caregivers to make it work, according to a recent study…
Before Americans become eligible for Medicare at 65, they often rely on private insurance. But for people who start showing signs of Alzheimer’s in…
On October 23nd, the UK’s drug regulation agency — UK Medicines and Healthcare products Regulatory Agency — approved Eli Lilly’s anti-amyloid drug Kisunla for…
Medicare covers the cost of the anti-amyloid Alzheimer’s drug Leqembi, but many people with Alzheimer’s are under the age of 65 and don’t yet…
C. Everett Koop, the avuncular doctor with a fluffy white beard who served as the U.S. surgeon general during the Reagan administration, was famous…
Scientists are looking for ways to detect cognitive decline and Alzheimer’s faster, so that they could treat the disease sooner. The holy grail of…
If your parents have Alzheimer’s or you’ve found yourself caring for someone with the disease, you might be thinking about how to plan for…
Nothing is more exciting than when my favorite basketball team, the Toronto Raptors, announced that they were signing a star player that could help…
Scientists are looking for ways to detect cognitive decline and Alzheimer’s faster, so that they can treat the disease sooner. This research involves discovering…
As of a landmark policy change in October 2023, Medicare now covers PET scans to look for Alzheimer’s biomarker beta-amyloid in the brain for…
A new generation of Alzheimer’s treatments — groundbreaking, disease-modifying monoclonal antibody drugs — is on the rise, and two so far have hit the…
We arrived at the emergency vet at 1 a.m. Our 10-month-old kitten, Pippin, had started breathing oddly earlier in the day but we thought…
UPDATE: 3 March 2024, 8:21 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…